All posts by: Michael Zand

About Michael Zand

FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development – Endpoints News

Continue reading

2018-05-22 NEWS

Endpoints News

FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development
Endpoints News
Gottlieb discussed the FDA’s policy plans for gene therapy Tuesday at the annual board meeting of the Alliance for Regenerative Medicine. Quoting an MIT study that predicts 40 FDA-approved gene therapy products by the end of 2022, he acknowledged …
Gene Therapies That Could Transform Diseases Get Easier FDA …Bloomberg
FDA plans to speed path to approval for some gene therapies – StatSTAT
Gene therapies get easier path to FDA approvalSFGate
Regulatory Focus –StreetInsider.com
all 7 news articles »